Which treatment modality should we choose for advanced hepatocellular carcinoma?

Korean J Hepatol. 2010 Dec;16(4):353-4. doi: 10.3350/kjhep.2010.16.4.353.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols
  • Benzenesulfonates / administration & dosage
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / therapy*
  • Chemoembolization, Therapeutic
  • Cisplatin / administration & dosage
  • Fluorouracil / administration & dosage
  • Humans
  • Infusions, Intra-Arterial
  • Liver Neoplasms / mortality
  • Liver Neoplasms / therapy*
  • Middle Aged
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / administration & dosage
  • Sorafenib
  • Survival Rate

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib
  • Cisplatin
  • Fluorouracil